Jennison Associates
BIIB icon

Jennison Associates’s Biogen BIIB Stock Holding History

Jennison Associates’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30,000
Closed -$8.39M – 674
2021
Q1 		$8.39M Buy
30,000
+10,000
+50% +$2.7M 0.01% 439
2020
Q4 		$4.9M Buy
+20,000
New +$5.16M ﹤0.01% 461
2018
Q1 		– Sell
-25,000
Closed -$7.96M – 658
2017
Q4 		$7.96M Buy
+25,000
New +$8.02M 0.01% 476
2017
Q1 		– Sell
-80,000
Closed -$22.7M – 663
2016
Q4 		$22.7M Buy
80,000
+60,000
+300% +$17.8M 0.03% 399
2016
Q3 		$6.26M Buy
+20,000
New +$5.92M 0.01% 500

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates's BIIB Position: Q2 2023 in Review

Jennison Associates sold out of Biogen (BIIB) in Q2 2023, closing a stake of 61,787 shares — an estimated $17.2M sold.

Jennison Associates first reported a position in BIIB in Q2 2013 and held it in 27 quarters. The position peaked at $2.15B in Q1 2015. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • Jennison Associates reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
  • Jennison Associates sold 61,787 Biogen shares in Q2 2023, an estimated $17.2M.
  • Jennison Associates first reported a position in Biogen in Q2 2013 and held it in 27 quarters.
  • Jennison Associates's Biogen position peaked at $2.15B in Q1 2015.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Jennison Associates's 13F filing for Q2 2023, filed 3 Aug 2023.